The Ludwig Institute for Cancer Research is a global non profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

To develop cancer vaccines, LICR and the Cancer Research Institute (CRI) in New York, USA have established the Cancer Vaccine Collaborative, an innovative partnership between two not-for-profit groups that are committed to taking responsibility for translating their laboratory discoveries into effective cancer therapies. More »
Jeanne Tie, MD, from the Melbourne Branch of the international Ludwig Institute for Cancer Research was presented with The Bradley Stuart Beller Merit Award at an awards ceremony held at the American Society of Clinical Oncology (ASCO) annual meeting in Florida.
Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have uncovered a remarkable property of the contractile ring, a structure required for cell division. Understanding how the contractile ring works to divide the cell may facilitate development of therapies to prevent uncontrolled cell division in cancer.